UNITED STATES

SECURITIES AND EXCHANGE COMMISSION ~~Washington, D.C. 20549~~

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~June~~July 248, 2022

~~Signet~~Golden ~~International~~Ally ~~Holdings~~Lifetech Group, Inc.

(Exact name of registrant as specified in its charter)

Delaware

000-51185

16-1732674

(State or other jurisdiction

of incorporation or organization

(Commission File #)

(IRS Employer

Identification No.)

901 S. Mopack Exp Building 1, Suite 300, Austin, TX 78746
(Address of principal executive offices)

512-430-1553 (Registrant’s telephone number, including area code)

~~(Registrant’s~~Signet ~~telephone~~International ~~number~~Holdings, ~~including area code)~~Inc.

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

	☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

	☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

	☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

	☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1 5.0103 ~~Entry~~Amendments ~~into~~to aArticles ~~Material~~of ~~Definitive~~Incorporation ~~Agreement.~~or Bylaws; Change in Fiscal Year

On ~~June~~July 248, 2022, Golden Ally Lifetech Group, Inc. (“Golden Ally”), awas ~~subsidiary~~merged ofwith and into Signet International Holdings, Inc.~~, entered~~ ~~into a Bottling Agreement~~ (the “~~Agreement~~Company”) ~~with~~pursuant ~~Azure~~to ~~Water~~a ~~Bottling~~Certificate of ~~Florida,~~Ownership ~~LLC~~and Merger (the “~~Azure~~Certificate”) ~~pursuant~~filed towith ~~which~~the Delaware ~~Azure~~Secretary ~~will~~of ~~produce,~~State. ~~bottle,~~Prior ~~label~~to ~~and~~that ~~ship~~merger, Golden Ally’s ~~AQP~~was ~~active~~a ~~water~~subsidiary ~~products~~of the Company. ~~The~~In ~~Agreement~~connection iswith ~~for~~the anmerger, ~~initial~~the ~~one-year~~Company ~~term,~~effectuated ~~subject~~an amendment to ~~potential~~its ~~renewal~~Certificate atof Incorporation to change the ~~election~~corporate name of ~~Golden~~the ~~Ally.~~Company ~~Azure~~(the is“Name anChange”) ~~integrated~~from ~~OEM~~“Signet International ~~bottler~~Holdings, ~~that~~Inc.” ~~supplies~~to ~~many~~“Golden ~~beverage~~Ally ~~products on~~Lifetech ~~the~~Group, ~~market~~Inc.”

~~The~~As ~~Agreement~~previously ~~sets~~disclosed ~~the~~in ~~prices~~various current and ~~terms~~periodic reports filed by ~~which~~the ~~Azure~~Company ~~will~~with ~~produce,~~the ~~bottle~~Securities and Exchange Commission, ~~label~~including a ~~and~~Current ~~ship~~Report ~~products~~on ~~for~~Form ~~Golden~~8-K ~~Ally,~~filed ~~and~~on ~~also~~April ~~sets~~11, ~~the~~2022, ~~parameters for~~pursuant ~~the~~to ~~product~~a ~~order~~Share Purchase and ~~size~~Exchange ~~requirements~~Agreement dated February 28, ~~and~~2022 ~~other~~(the “SPA”) ~~matters~~in ~~such~~April as2022, ~~quality~~the ~~control~~Company and ~~production~~the ~~process~~other ~~control.~~parties ~~Under~~to the ~~Agreement~~ SPA closed on certain transactions whereby Golden Ally ~~will~~became a ~~make~~subsidiary ~~available~~of ~~and~~the ~~license~~Company. toIn ~~Azure~~connection ~~certain~~with ~~technology~~those ~~and~~transactions, ~~rights~~as previously disclosed in ~~order~~an ~~for~~Information ~~Azure~~Statement todated ~~produce~~March 16, 2022 filed with the Securities and ~~package~~Exchange Commission and disseminated to the ~~products~~Company’s stockholders, the Company’s stockholders ~~and~~approved ~~Golden~~various ~~Alley~~corporate ~~will~~actions, ~~remain~~including the ~~owner~~Name Change. The Name Change was effectuated after the receipt of ~~any~~approval ~~such~~from ~~technology~~Financial Industry ~~and~~Regulatory ~~rights~~Authority, Inc. (“FINRA”).

InA ~~addition,~~copy ~~the~~of ~~Agreement provides that Azure will produce, package and label~~ the ~~products~~Certificate ~~pursuant~~is tofiled ~~forecasts~~as ~~and~~Exhibit ~~purchase~~3.1 ~~orders issued by Golden Alley, and according~~ to ~~the specifications provided to Azure by Golden Ally. The Agreement includes various other terms and conditions that are customary for an agreement of~~ this ~~nature,~~Current ~~including~~Report ~~provisions~~on ~~related~~Form to8-K ~~delivery of the products~~ and ~~risk~~incorporated ofherein ~~loss, product~~by ~~inspection rights, insurance covenants of each party, representations and warranties of the parties that are customary for an agreement of this nature, and compliance obligations of each party~~reference.

~~The~~Item foregoing summary of the Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Agreement, which will be filed with the Securities and Exchange Commission (the “SEC”) as an exhibit to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2022 or via an amendment to this Current Report on Form 8-K.01 ~~Pursuant~~Other to Item 601(b)(10) of Regulation S-K, certain terms of the Agreement have been omitted from this Current Report on Form 8-K, and will be omitted from the version of the Agreement to be filed with the SEC, because such terms are (i) not material and (ii) private and confidential to the partiesEvents.

Prior to effecting the Name Change, the Company submitted to FINRA a voluntary request for the change of the Company’s trading symbol. After the Name Change the trading symbol for the Company’s common stock will be “AQPW”. It is expected that the Name Change and new trading symbol will be declared effective in the market by FINRA on or about July 13, 2022.

Item 9.01 Financial Statements and Exhibits.

(d)	Exhibits. The following exhibits are filed or furnished with this report:

	3.1	Certificate of Ownership and Merger

	104	Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL document (contained in Exhibit 101)

SIGNATURE

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	SIGNET INTERNATIONAL HOLDINGS, INC.
	GOLDEN ALLY LIFETECH GROUP, INC.
Dated: June 30, 2022	By:	/s/ Oliver Keren Ban
Dated: July 13, 2022	By:	/s/ Oliver Keren Ban
	Name:	Oliver Keren Ban
	Title:	Chief Executive Officer

Filing Compare · Golden Ally Lifetech Group, Inc.